Under the law, Medicare will now be allowed to negotiate the cost of some drugs; vaccines will be free for Part D recipients
However, 86.6 percent of people with opioid use disorder are not receiving medication treatment
Meta-analyses suggest positive effects of noradrenergic drugs on global cognition, apathy
Increase in methadone-involved deaths in March 2020 not thought to be tied to expanded opioid treatment program take-home policies
Small pilot study suggests suvorexant may improve sleep, reduce opioid withdrawal and craving during buprenorphine/naloxone taper
Trial was the first to test a drug meant to delay or halt mental decline in people who have a genetic predisposition
Relative change from 2016 to 2019 varied from −52.0 percent in Mississippi to −6.9 percent in New Hampshire
At pandemic outset, significant decreases in buprenorphine prescription fills seen for Black, Hispanic patients, but not White patients
Risks for ASD, intellectual disability may be increased with prenatal exposure to topiramate, valproate, certain duotherapies
Pharmacotherapy for alcohol use disorder linked to reduced incidence of hepatic decompensation in patients with cirrhosis